Item 8.01 Other Events.

On June 26, 2022, Brookline Capital Acquisition Corp., a Delaware corporation ("BCAC"), entered into Amendment No. 1 (the "Amendment") to the Business Combination Agreement dated as of March 17, 2022 among BCAC, Project Barolo Merger Sub, Inc., a Delaware corporation, and Apexigen, Inc., a Delaware corporation (the "Business Combination Agreement"), in order to increase the number of directors of the BCAC Board and the board of directors of the Surviving Corporation upon the Effective Time (such capitalized terms as defined in the Business Combination Agreement) from seven to eight directors, and to increase the number of directors selected by Apexigen from six to seven directors. The Amendment is filed as Exhibit 2.1 hereto and incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits:

Exhibit                                  Description

2.1           Amendment No. 1 to Business Combination Agreement dated as of
            June 26, 2022 among Brookline Capital Acquisition Corp., a Delaware
            corporation, Project Barolo Merger Sub, Inc., a Delaware corporation,
            and Apexigen, Inc., a Delaware corporation.

104         Cover page Interactive data file (embedded with in the inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses